Cathie Wood's Ark Invest Trims Palantir Again As Peter Thiel Co-Founded Firm's Stock Tumbles Nearly 15% In 2025

On Monday, Cathie Wood-led Ark Invest made significant trades in five major companies: Palantir Technologies Inc. PLTR, Tempus AI Inc. TEM, CareDx Inc. CDNA, Veracyte Inc. VCYT, Adaptive Biotechnologies Corp. ADPT.

The PLTR Trade

Ark Invest’s Ark Innovation ETF ARKK fund sold 140,518 shares of Palantir. This move is significant, considering Ark Invest’s recent trend of offloading Palantir shares.

The total value of this trade, based on the latest closing price of $64.98, is approximately $9.1 million.

This sale follows Ark’s disposal of shares worth roughly $15 million the previous week.

Palantir stock price has fallen more than 14% over the past month. In just the first two weeks of 2025, the stock has declined nearly 15%.

The TEM Trade

Ark Invest’s ARK Genomic Revolution ETF ARKG and ARKK funds made substantial purchases of Tempus AI Inc. shares. The ARKG fund bought 98,691 shares, while the ARKK fund purchased a whopping 280,192 shares.

Given the latest closing price of $32.34, the total value of these trades amounts to approximately $12.2 million.

This move comes amid TEM’s 13.81% drop on Monday.

Other Key Trades:

Company	ETF	Transaction	No. Of Shares	Closing price	Approx. Value
Veracyte Inc. VCYT	ARK Genomic Revolution	Sale	37,358	$42.78	$1.6 million
Adaptive Biotechnologies Corp. ADPT	ARK Genomic Revolution	Sale	76,522	$6.46	$494,332
CareDx Inc. CDNA	ARK Genomic Revolution	Sale	65,550	$25.07	$1.6 million

Closing price as of Jan. 13, 2025

Read Next:

• Mark Zuckerberg Critiques ‘Culturally Neutered’ Companies, Advocates For ‘Masculine Energy’ As Meta Cuts DEI Programs Post-Joe Rogan Appearance

Image via Benzinga YouTube and Unsplash

This story was generated using Benzinga Neuro and edited by Rounak Jain